UnknownPhase 2NCT03944447

Outcomes Mandate National Integration With Cannabis as Medicine

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
OMNI Medical Services, LLC
Principal Investigator
Dr. Ryan O Lakin, MD JD
OMNI Medical Services Inc
Intervention
Cannabis, Medical(drug)
Enrollment
200000 enrolled
Eligibility
7 years · All sexes
Timeline
20182025

Study locations (16)

Collaborators

OMNI Medical Services Inc

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03944447 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials